←
Tom Stanis480 posts
Tom Stanis avatar

Tom Stanis

@tomstanis

Founder & CEO of @StoryHealthAI Previously Co-Founder and Head of Software @verilylifesci Former Principle Engineer @Google

◷ Joined July 2012▧ 32 Photos and videos
Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

6/ Bottom line: this study does not show that statins cause dementia. Its design can’t separate a drug effect from these biases, and better evidence points the other way.

Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

5/ The tell: a doubled risk conflicts with randomized trials and genetic studies, which don’t show this harm. Big effects and dose-response patterns can come from bias too. Stronger tests would compare against another drug, check outcomes statins shouldn’t affect, and fix the entry timing.

Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

4/ Survivorship bias: follow-up starts as early as 2006, but All of Us didn’t enroll anyone until 2018. People had to survive for years just to get into the study. Those who died first, like high-risk people who never got statins, are invisible.

Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

3/ Hidden variables: adjustment only fixes what’s measured. This study had no data on education, income, smoking, or how often people see doctors. Statin users are in clinics more, so memory problems get noticed and coded more. The dementia codes even include mild cognitive impairment.

Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

2/ Confounding by indication: statin users start out sicker. Before adjustment, 50% had hypertension vs 16% of non-users. Statistical weighting balanced the yes/no boxes, but not how severe or long-lasting those conditions were.

Tom Stanis avatar
Tom Stanis@tomstanis·Nov 1

1/ 1/ A new study is being read as “statins double dementia risk.” It doesn’t show that. It found more dementia diagnoses among statin users in two health databases, and its design can’t tell you why. Here’s what goes wrong in studies like this 🧵 frontiersin.org/journals/pha…

Tom Stanis avatar
Tom Stanis@tomstanis·Sep 17

I love this work. Engineers are the modern day explorers. We must keep plowing the dark.

SpaceX@SpaceXSep 16

A fully and rapidly reusable rocket will fundamentally change how humanity accesses outer space. “The Holy Grail of Rocketry” continues the ongoing Starship series with a look back at the scrappy days of SpaceX engineers proving reuse was possible and takes you onboard a high-seas race to recover a floating Starship

28:29
Tom Stanis avatar
Tom Stanis@tomstanis·Sep 17

I believe this is the beginning of the “Rats of NIMH”

An extraordinary @Nature paper has just landed from the lab of @Sergiu_P_Pasca at @Stanford - led by Konstantin Kaganovsky. They have found a way to create "xenocortical mice" which have ~92% of their cortex occupied by a cortical organoid derived from human stem cells. This human-derived cortical graft integrates deeply with the host nervous system, supporting organised neural activity and behaviour. This study is a milestone in synthetic biology and chimera research. It has the potential to generate multiple medical breakthroughs by providing an enhanced biological model of human brain tissue that allows behavioural as well as neural and genetic assays. The Stanford team have been exceptionally thorough and proactive in addressing ethical concerns that comes from this frontier work. But their pioneering work nonetheless raises many open questions: are the xenocortical mice conscious? Do they have any human-like properties of consciousness or cognition? @NitaFarahany and I will be addressing some of these questions in a forthcoming commentary - where we'll also offer an ethically-informed roadmap to guide this important research as it progresses. In this context, "pacing the frontier" really does make sense 😉 Read the Stanford @nature paper here, and buckle up. It's wild. nature.com/articles/s41586-0…

Post attachment
NASA avatar
⟳ Tom Stanis retweeted
NASA@NASA·Aug 29

Ready for launch, ready to change how we view the cosmos. After years of careful planning, testing, and construction, @NASARoman is ready for liftoff tomorrow, Aug. 30.

3:13
Tom Stanis avatar
Tom Stanis@tomstanis·29 Jul 2025

This is going to help so many patients.

Mark Cuban@mcuban28 Jul 2025

If you take Entresto, we now have the generic and it starts at $33.75 ! It's probably lower than your deductible or Coinsurance. So check it out with your doctor !

The Humanoid Hub avatar
⟳ Tom Stanis retweeted
The Humanoid Hub@TheHumanoidHub·12 Jul 2025

Pollen Robotics, a Hugging Face subsidiary, has open-sourced Amazing Hand, a 3D-printable, four-finger robotic hand with eight degrees of freedom (DoF). Weighing 400g and costing less than $250 - it is designed for Reachy2’s wrist but adaptable to other robots.

0:13

Hugging Face has acquired a French robotics startup, Pollen Robotics, for an undisclosed amount. The Reachy 2 robot, developed by Pollen, is an open-source and VR-compatible bimanual robot for advancing embodied AI, available to order at $70K. Hugging Face, the leading platform for sharing and fine-tuning LLMs, is also building LeRobot - a platform for providing models, tools, and datasets for robotics AI. Hugging Face was valued at $4.5B in the last round.

2:23
Tom Stanis avatar
Tom Stanis@tomstanis·6 Apr 2025

I’ve had weekends where I felt completely lost, only to show up Monday with a plan I was excited to share. Not because I found the answer, but because I stopped trying to solve and started trying to describe. Here’s how I use GenAI to break out of mental loops and rediscover momentum: medium.com/@tstanis/out-of-t…